| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2432997f9dd07522f631509ed856a31d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-497
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 |
| filingDate |
2010-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2015-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c396cdb4e8843b6de31f0a83fc4b9af
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fef5d7a064ef9207f9f128d41179568a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_38bec0bf258791fba29e3780791755eb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_babc6419ede943027f41bff3ba0be8c7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77306c82b30e2f6d9b40695abe8d0f39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64bc4cc90e1d601adf7cc56a06bef296
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_897b4a76bf0b4bd660adf75ef05a783b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba9b1b7b27e4fb0334e967ed8e756087 |
| publicationDate |
2015-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2488519-B1 |
| titleOfInvention |
Pyrazolopyridine derivatives as anticancer agent |
| priorityDate |
2009-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |